NEUROPHET, Inc. (KOSDAQ:380550)
South Korea · Delayed Price · Currency is KRW 27,000
-2,600 (-8.78%)
At close: Feb 6, 2026
NEUROPHET Market Cap
NEUROPHET has a market cap or net worth of 314.84 billion as of February 6, 2026.
Market Cap
314.84B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
27,000.00
Market Cap Chart
Since July 25, 2025, NEUROPHET's market cap has increased from 232.96B to 314.84B, an increase of 35.15%. That is a compound annual growth rate of 75.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 314.84B | 21.60% |
| Dec 30, 2025 | 258.91B | 11.14% |
| Jul 25, 2025 | 232.96B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 77.21T |
| Celltrion | 48.14T |
| ALTEOGEN | 19.31T |
| Sam Chun Dang Pharm. | 11.63T |
| Yungjin Pharm. | 339.27B |
| Hyundai Pharmaceutical | 328.81B |
| Bioneer | 325.98B |
| BNC Korea | 316.67B |